FDA announces shortage of all blood specimen tubes, strategies to conserve
![FDA](/sites/default/files/styles/900x400/public/2018-07/FDA.jpg?itok=kyInjubn)
The Food and Drug Administration yesterday expanded its medical device shortage list to include all blood specimen collection tubes and recommended health care providers, laboratory directors and others consider certain strategies to conserve their use. The agency said it continues to monitor the situation and provide updates as new information becomes available. The shortage previously was limited to sodium citrate tubes.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…